Cofrogliptin

DRUG2 trials

Sponsors

Haisco Pharmaceutical Group Co., Ltd., Second Xiangya Hospital of Central South University

Conditions

Latent Autoimmune Diabetes in Adults (LADA)Type 2 Diabetes

Unknown Phase

A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes

Not yet recruitingNCT07122102

Haisco Pharmaceutical Group Co., Ltd.Type 2 Diabetes

Start: 2025-10-01End: 2027-07-30Target: 200Updated: 2025-09-26

Effects of Cofrogliptin on Beta-Cell Function in LADA Patients

Not yet recruitingNCT07460336

Second Xiangya Hospital of Central South UniversityLatent Autoimmune Diabetes in Adults (LADA)

Start: 2026-05-15End: 2027-12-31Target: 84Updated: 2026-05-08